7WZ-21388-98369
4 vaccinations
9 coded responses
45 check-ins
9 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 752 / TX
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-30
Registered in v-safe
- 2020-12-30
- 2021-01-02
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Chills, Headache, Injection site erythema, Lymphadenopathy, Myalgia, Pyrexia — Feeling: Good · Site: Pain, Redness, Swelling, ItchingFree text: 12 hours after the 2nd dose, I got chills and low grade fever. The following day I had headache and myalgias. By 2 days after I was feeling better. Still have site redness and axillary lymphadenopathy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Mild left axillary lymphadenopathy, improving (vaccine given in left arm both times)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-04-10
- 2021-07-10
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2021-09-30
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaFree text: Axillary LymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Significant axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaFree text: Tender Axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
- 2021-10-06
- 2021-10-07
- 2021-10-14
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2021-12-30
- 2022-03-31
-
2022-10-07
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-07
- 2022-10-07
-
2022-10-08
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-09
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2022-10-10
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Lymphadenopathy of axillaMedDRA releases: 2024-11 · check-in free text available
- 2022-10-11
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-22
- 2022-10-28
- 2022-11-04
- 2022-11-11
- 2022-11-18
- 2023-01-06
- 2023-04-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-10-07 | Pfizer-BioNTech | Flu |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): 12 hours after the 2nd dose, I got chills and low grade fever. The following day I had headache and myalgias. By 2 days after I was feeling better. Still have site redness and axillary lymphadenopathy.
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Mild left axillary lymphadenopathy, improving (vaccine given in left arm both times)
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Axillary Lymphadenopathy
Systemic reaction (other): Significant axillary lymphadenopathy
Systemic reaction (other): Tender Axillary lymphadenopathy
Systemic reaction (other): Axillary lymphadenopathy
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Axillary lymphadenopathy
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Axillary lymphadenopathy
Systemic reaction (other): Lymphadenopathy of axilla
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release